Publication
Liquid biopsy for early detection of pancreatic ductal adenocarcinoma.
Caiming Xu, Alessandro Mannucci, Haiyong Han, Ruben M Munoz, Derek Cridebring, Sourat Darabi, Yuji Toiyama, Yoshinaga Okugawa, Gagandeep Singh, Mustafa Raoof, Joon Oh Park, James Lin, Gregory Idos, Michael J Demeure, Erkut Borazanci, Douglas B Evans, Susan Tsai, Eunsung Jun, Carlos Becerra, Scott A Celinski, Laleh Melstrom, Vincent Chung, Guixin Zhang, Dong Shang, David L Bartlett, Mitsuro Kanda, Song Cheol Kim, Valsamo Anagnastou, Giulia Martina Cavestro, John S Bolton, Ali H Zaidi, Daniel Von Hoff, Ajay Goel
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
There is no clinically relevant blood-based assay for the detection of early-stage pancreatic ductal adenocarcinoma (PDAC), a solid malignancy characterized by poor outcomes. Here we developed, validated and tested a blood-based microRNA (miRNA) assay (which included hsa-miR-142-3p, hsa-miR-30c-5p,…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 1
- trialNCT06388967registry_reference1.00
Registered trialsNCT06388967
Curated evidence
Evidence citing this paper (0)
Data not yet available